Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients

被引:141
作者
Palmedo, H. [1 ,2 ]
Marx, C. [3 ]
Ebert, A. [1 ,2 ]
Kreft, B. [1 ,2 ]
Ko, Y. [5 ]
Tuerler, A. [6 ]
Vorreuther, R. [7 ]
Goehring, U. [8 ]
Schild, H. H. [3 ]
Gerhardt, T. [9 ]
Poege, U. [9 ]
Ezziddin, S. [4 ]
Biersack, H. -J. [4 ]
Ahmadzadehfar, H. [4 ]
机构
[1] Johanniter Hosp, Inst Radiol & Nucl Med, D-53113 Bonn, Germany
[2] Johanniter Hosp, PET CT Ctr, D-53113 Bonn, Germany
[3] Univ Hosp, Dept Radiol, Bonn, Germany
[4] Univ Hosp, Dept Nucl Med, Bonn, Germany
[5] Johanniter Hosp, Dept Internal Med, Ctr Clin Canc, D-53113 Bonn, Germany
[6] Johanniter Hosp, Dept Surg, D-53113 Bonn, Germany
[7] Waldkrankenhaus Hosp, Dept Urol, Bonn, Germany
[8] Johanniter Hosp, Dept Obstet & Gynecol, D-53113 Bonn, Germany
[9] Inst Internal Med Nephrol, Bonn, Germany
关键词
SPECT/CT; Bone scintigraphy; Bone metastases; Prostate cancer; Breast cancer; PROSTATE-CANCER; EMISSION-TOMOGRAPHY; BREAST-CANCER; CT; ACCURACY; LESIONS; METASTASES; PET/CT;
D O I
10.1007/s00259-013-2532-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This study was designed to assess the additional value of SPECT/CT of the trunk used in conjunction with conventional nuclear imaging and its effects on patient management in a large patient series. In 353 patients, whole-body scintigraphy (WBS), SPECT, and SPECT/CT were prospectively performed for staging and restaging. SPECT/CT of the trunk was performed in all patients. In the 308 evaluable patients (211 with breast cancer, 97 with prostate cancer), clinical follow-up was used as the gold standard. Bone metastases were confirmed in 72 patients and excluded in 236. Multistep analyses per lesion and per patient were performed. Clinical relevance was expressed in terms of downstaging and upstaging rates on a per-patient basis. In the total patient group, sensitivities, specificities, and negative and positive predictive values on a per-patient basis were 93 %, 78 %, 95 % and 59 % for WBS, 94 %, 71 %, 97 % and 53 % for SPECT, and 97 %, 94 %, 97 % and 88 % for SPECT/CT, respectively. In all subgroups, specificity and positive predictive value were significantly (p < 0.01) better with SPECT/CT. Downstaging of metastatic disease in the total, breast cancer and prostate cancer groups using SPECT/CT was possible in 32.1 %, 33.8 % and 29.5 % of patients, respectively. Upstaging in previously negative patients by additional SPECT/CT was observed in three breast cancer patients (2.1 %). Further diagnostic imaging procedures for unclear scintigraphic findings were necessary in only 2.5 % of patients. SPECT/CT improved diagnostic accuracy for defining the extent of multifocal metastatic disease in 34.6 % of these patients. SPECT/CT significantly improved the specificity and positive predictive value of bone scintigraphy in cancer patients. In breast cancer patients, we found a slight increase in sensitivity. SPECT/CT had a significant effect on clinical management because of correct downstaging and upstaging, better definition of the extent of metastases, and a reduction in further diagnostic procedures.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 18 条
  • [1] Baseline staging of newly diagnosed prostate cancer: A summary of the literature
    Abuzallouf, S
    Dayes, I
    Lukka, H
    [J]. JOURNAL OF UROLOGY, 2004, 171 (06) : 2122 - 2127
  • [2] Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
    Bubendorf, L
    Schöpfer, A
    Wagner, U
    Sauter, G
    Moch, H
    Willi, N
    Gasser, TC
    Mihatsch, MJ
    [J]. HUMAN PATHOLOGY, 2000, 31 (05) : 578 - 583
  • [3] Even-Sapir E, 2006, J NUCL MED, V47, P287
  • [4] The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate
    Helyar, Vincent
    Mohan, Hosahalli K.
    Barwick, Tara
    Livieratos, Lefteris
    Gnanasegaran, Gopinath
    Clarke, Susan E. M.
    Fogelman, Ignac
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (04) : 706 - 713
  • [5] Evaluation of combined transmission and emission tomography for classification of skeletal lesions
    Horger, M
    Eschmann, SM
    Pfannenberg, C
    Vonthein, R
    Besenfelder, H
    Claussen, CD
    Bares, R
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 183 (03) : 655 - 661
  • [6] Imaging bone metastases in breast cancer: evidence on comparative test accuracy
    Houssami, N.
    Costelloe, C. M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (04) : 834 - U1
  • [7] Nömayr A, 2006, NUCL MED COMMUN, V27, P521
  • [8] Palmedo H, 2006, J NUCL MED, V47, P616
  • [9] Benign versus malignant osseous lesions in the lumbar vertebrae: differentiation by means of bone SPET
    Reinartz, P
    Schaffeldt, J
    Sabri, O
    Zimny, M
    Nowak, B
    Ostwald, E
    Cremerius, U
    Buell, U
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (06) : 721 - 726
  • [10] Römer W, 2006, J NUCL MED, V47, P1102